Neurocea Competitors and Similar CompaniesClear all
Neurocea's competitors and similar companies include CerSci Therapeutics, Neopharm Boston and Terns Pharmaceuticals.
 Neurocea Neurocea is a biopharmaceutical company engaged in developing oral therapy for CNS (central nervous system) diseases. |  CerSci Therapeutics CerSci Therapeutics is a biotechnology company focused on delivering a new generation of non-opioid medicines. |  Neopharm Boston Neopharm Boston (formerly Averica Discovery Services) is an analytical development contract research organization. |  Terns Pharmaceuticals Terns Pharmaceuticals is a biopharmaceutical company developing small-molecule single-agent and combination therapy for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases. | |
Founding Date | Founding Date 2012 | Founding Date 2015 | Founding Date 2007 | Founding Date 2017 |
Type | Type Private | Type Subsidiary | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations US HQ | Locations Dallas, US HQ | Locations Marlborough, US HQ | Locations Foster City, US HQ |
Employees | Employees 7 | Employees 7 | Employees 717% increase | Employees 59 |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 5.7m | Total funding raised N/A | Total funding raised $ 30m |
For sources of this data, please see the company profile
View Company Profiles
CerSci Therapeutics
HQ
Dallas, US
CerSci Therapeutics is a biotechnology company focused on delivering a new generation of non-opioid medicines.
View companyNeopharm Boston
HQ
Marlborough, US
Neopharm Boston (formerly Averica Discovery Services) is an analytical development contract research organization.
View companyTerns Pharmaceuticals
HQ
Foster City, US
Employees
59
Terns Pharmaceuticals is a biopharmaceutical company developing small-molecule single-agent and combination therapy for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases.
View company